お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
980751

デジタルPCR市場の成長機会・成長予測 (2020-2027年): 技術・製品タイプ・用途・エンドユーザー・地域別

Digital PCR Market by Treatment Type, Product Type, Application, and End User : Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 237 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
デジタルPCR市場の成長機会・成長予測 (2020-2027年): 技術・製品タイプ・用途・エンドユーザー・地域別
出版日: 2020年11月27日
発行: Allied Market Research
ページ情報: 英文 237 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルPCRの市場規模は予測期間中12.3%のCAGRで推移し、2019年の3億9800万米ドルから、2027年には10億5200万米ドルの規模に成長すると予測されています。感染症の有病率の上昇、個別化医療の認知度および受容度の向上、技術の進歩などの要因が同市場の成長を推進する見通しです。一方で、dPCRデバイスの高コスト性、償還上の課題などの要因が市場のさらなる成長の妨げとなる見通しです。

当レポートでは、世界のデジタルPCRの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、技術・製品タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義・調査範囲
  • 主要調査結果
  • ポーターのファイブフォース分析
  • 主要企業の位置付け
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19の影響

第4章 市場分析・予測:技術別

  • 概要
  • 液滴デジタルPCR
  • BEAMing法
    • 主要動向・成長要因・市場機会
    • 市場規模・予測
    • 市場分析:国別

第5章 市場分析・予測:製品タイプ別

  • 概要
  • 消耗品・試薬
  • デジタルPCRシステム
  • ソフトウェア・サービス
    • 市場規模・予測
    • 市場分析:国別

第6章 市場分析・予測:用途別

  • 概要
  • 研究
  • 臨床診断
  • 法医学など
    • 市場規模・予測
    • 市場分析:国別

第7章 市場分析・予測:エンドユーザー別

  • 概要
  • 臨床診断ラボ
  • 製薬・バイオテクノロジー産業
  • 大学・その他の組織
    • 市場規模・予測
    • 市場分析:国別

第8章 市場分析・予測:地域・主要国別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • 技術別
    • 製品タイプ
    • 用途別
    • エンドユーザー別

第9章 企業プロファイル

  • BIO-RAD LABORATORIES, INC.
  • 4BASEBIO AG
  • COMBINATI, INC.
  • FLUIDIGM CORPORATION
  • JN MEDSYS
  • MERCK KGAA
  • QIAGEN N.V.
  • SYSMEX CORPORATION
  • STILLA TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC, INC.
図表

LIST OF TABLES

  • TABLE 01.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
  • TABLE 02.DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.BEAMING PCR MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 05.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 09.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 13.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.DIGITAL PCR MARKET REVENUE, BY REGION, 2019-2027($MILLION)
  • TABLE 17.NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 18.U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 19.U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 20.U.S. DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 21.U.S. DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 22.CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 23.CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 24.CANADA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 25.CANADA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 26.MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 27.MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 28.MEXICO DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 29.MEXICO DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 30.NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 31.NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 32.NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 33.NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 34.EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 35.GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 36.GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 37.GERMANY DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 38.GERMANY DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 39.FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 40.FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 41.FRANCE DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 42.FRANCE DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 43.UK DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 44.UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 45.UK DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 46.UK DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 47.ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 48.ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 49.ITALY DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 50.ITALY DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 51.SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 52.SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 53.SPAIN DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 54.SPAIN DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 55.REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 56.REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 57.REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 58.REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 59.EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 60.EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 61.EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 62.EUROPE DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 63.ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 64.JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 65.JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 66.JAPAN DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 67.JAPAN DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 68.CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 69.CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 70.CHINA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 71.CHINA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 72.AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 73.AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 74.AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 75.AUSTRALIA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 76.INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 77.INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 78.INDIA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 79.INDIA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 80.SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 81.SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 82.SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 83.SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 84.TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 85.TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 86.TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 87.TAIWAN DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 88.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 89.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 90.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 91.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 92.ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 93.ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 94.ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 95.ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 96.LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 97.BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 98.BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 99.BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 100.BRAZIL DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 101.SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 102.SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 103.SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 104.SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 105.SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 106.SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 107.SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 108.SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 109.REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 110.REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 111.REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 112.REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 113.LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019-2027($MILLION)
  • TABLE 114.LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 115.LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019-2027($MILLION)
  • TABLE 116.LAMEA DIGITAL PCR MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 117.BIO-RAD: COMPANY SNAPSHOT
  • TABLE 118.BIO-RAD: OERATING SEGMENT
  • TABLE 119.BIO-RAD: PRODUCT PORTFOLIO
  • TABLE 120.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121.4BASEBIO: COMPANY SNAPSHOT
  • TABLE 122.4BASEBIO: PRODUCT PORTFOLIO
  • TABLE 123.COMBINATI: COMPANY SNAPSHOT
  • TABLE 124.COMBINATI: PRODUCT PORTFOLIO
  • TABLE 125.COMBINATI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126.FLUIDIGM: COMPANY SNAPSHOT
  • TABLE 127.FLUIDIGM: PRODUCT PORTFOLIO
  • TABLE 128.JN MEDSYS: COMPANY SNAPSHOT
  • TABLE 129.JN MEDSYS: PRODUCT PORTFOLIO
  • TABLE 130.MERCK: COMPANY SNAPSHOT
  • TABLE 131.MERCK: OPERATING SEGMENTS
  • TABLE 132.MERCK: PRODUCT PORTFOLIO
  • TABLE 133.QIAGEN: COMPANY SNAPSHOT
  • TABLE 134.QIAGEN: PRODUCT SEGMENT
  • TABLE 135.QIAGEN: PRODUCT PORTFOLIO
  • TABLE 136.SYSMEX: COMPANY SNAPSHOT
  • TABLE 137.SYSMEX: OERATING SEGMENT
  • TABLE 138.SYSMEX.: PRODUCT PORTFOLIO
  • TABLE 139.STILLA: COMPANY SNAPSHOT
  • TABLE 140.STILLA: PRODUCT PORTFOLIO
  • TABLE 141.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 142.THERMO FISHER.: OERATING SEGMENT
  • TABLE 143.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.SEGMENTATION OF GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS, 2019
  • FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 05.HIGH THREAT OF SUBSTITUTION
  • FIGURE 06.LOW THREAT OF NEW ENTRANTS
  • FIGURE 07.MODERATE COMPETITIVE RIVALRY
  • FIGURE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: TOP PLAYER POSITIONING, 2019
  • FIGURE 09.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 11.COMPARATIVE SHARE ANALYSIS OF BEAMING PCR MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 21.BIO-RAD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 22.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 23.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 24.4BASEBIO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 25.FLUIDIGM: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 26.FLUIDIGM: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 27.FLUIDIGM: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 28.MERCK: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 29.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 30.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 31.QIAGEN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 32.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
  • FIGURE 33.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 34.SYSMEX: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 35.SYSMEX: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 36.SYSMEX: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 37.THERMO FISHER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 38.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 39.THERMO FISHER: REVENUE SHARE BY REGION, 2019 (%)
目次
Product Code: A00532

Title:
Digital PCR Market by Treatment Type (Droplet Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Opportunity Analysis and Industry Forecast, 2020-2027.

The global digital polymerase chain reaction market generated $398 million in 2019, and is projected to reach $1,052 million by 2027, growing at a CAGR of 12.3% from 2020 to 2027.

Digital polymerase chain reaction (dPCR) is a new approach for detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and others similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.

The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique is expected to boost the market growth during the forecast period. However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer remunerative opportunities for market players.

The global digital polymerase chain reaction market is segmented into technology, type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR.

Depending on type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global digital polymerase chain reaction market include Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc. Product launch and acquisition was the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.

KEY BENEFITS FOR STAKEHOLDERS

This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.

Quantitative analysis of the current trends and future estimations assist stakeholders to design business strategies accordingly.

Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.

Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

Key Market Segments

By Treatment Type

Droplet Digital PCR

BEAMing Digital PCR

By Product Type

Digital PCR Systems

Consumables & Reagents

Software & Services

By Application

Research

Clinical Diagnostics

Forensic & Others

By End User

Pharmaceuticals & Biotechnology Industries

Clinical Diagnostic Laboratories

Universities & Other Organizations

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

Australia

India

South Korea

Taiwan

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

List of key players profiled in the report

4basebio AG

Bio-Rad Laboratories, Inc.

Combinati, Inc.

Fluidigm Corporation

JN Medsys

Merck KGaA

Qiagen N.V.

Stilla Technologies

Sysmex Corporation

Thermo Fisher Scientific, Inc

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Promega Corporation

Takara Bio Inc.

Avance Biosciences Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Rise in prevalence of infectious diseases and cancer
      • 3.5.1.2.Increase in awareness and acceptance of personalized medicines
      • 3.5.1.3.Technological advancements
    • 3.5.2.Restraints
      • 3.5.2.1.High cost of dPCR devices
      • 3.5.2.2.Reimbursement issues
    • 3.5.3.Opportunity
      • 3.5.3.1.Increase in funding for R&D activities
  • 3.6.Impact analysis of COVID-19 on the digital PCR market

CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Droplet digital PCR
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.BEAMing dPCR
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country

CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Consumables & reagents
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Digital PCR systems
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Software & services
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country

CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Research
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.Clinical diagnostics
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Forensic & others
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country

CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Clinical diagnostic laboratories
    • 7.2.1.Market size and forecast
    • 7.2.2.Market analysis, by country
  • 7.3.Pharmaceuticals & biotechnology industries
    • 7.3.1.Market size and forecast
    • 7.3.2.Market analysis, by country
  • 7.4.Universities & other organizations
    • 7.4.1.Market size and forecast
    • 7.4.2.Market analysis, by country

CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION

  • 8.1.OVERVIEW
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.North America digital PCR market, by country
      • 8.2.2.1.U.S. digital PCR market, by technology
      • 8.2.2.2.U.S. digital PCR market, by product type
      • 8.2.2.3.U.S. digital PCR market, by application
      • 8.2.2.4.U.S. digital PCR market, by end user
      • 8.2.2.5.Canada digital PCR market, by technology
      • 8.2.2.6.Canada digital PCR market, by product type
      • 8.2.2.7.Canada digital PCR market, by application
      • 8.2.2.8.Canada digital PCR market, by end user
      • 8.2.2.9.Mexico digital PCR market, by technology
      • 8.2.2.10.Mexico digital PCR market, by product type
      • 8.2.2.11.Mexico digital PCR market, by application
      • 8.2.2.12.Mexico digital PCR market, by end user
    • 8.2.3.North America digital PCR market, by technology
    • 8.2.4.North America digital PCR market, by product type
    • 8.2.5.North America digital PCR market, by application
    • 8.2.6.North America digital PCR market, by end user
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Europe digital PCR market, by country
      • 8.3.2.1.Germany digital PCR market, by technology
      • 8.3.2.2.Germany digital PCR market, by product type
      • 8.3.2.3.Germany digital PCR market, by application
      • 8.3.2.4.Germany digital PCR market, by end user
      • 8.3.2.5.France digital PCR market, by technology
      • 8.3.2.6.France digital PCR market, by product type
      • 8.3.2.7.France digital PCR market, by application
      • 8.3.2.8.France digital PCR market, by end user
      • 8.3.2.9.UK digital PCR market, by technology
      • 8.3.2.10.UK digital PCR market, by product type
      • 8.3.2.11.UK digital PCR market, by application
      • 8.3.2.12.UK digital PCR market, by end user
      • 8.3.2.13.Italy digital PCR market, by technology
      • 8.3.2.14.Italy digital PCR market, by product type
      • 8.3.2.15.Italy digital PCR market, by application
      • 8.3.2.16.Italy digital PCR market, by end user
      • 8.3.2.17.Spain digital PCR market, by technology
      • 8.3.2.18.Spain digital PCR market, by product type
      • 8.3.2.19.Spain digital PCR market, by application
      • 8.3.2.20.Spain digital PCR market, by end user
      • 8.3.2.21.Rest of Europe digital PCR market, by technology
      • 8.3.2.22.Rest of Europe digital PCR market, by product type
      • 8.3.2.23.Rest of Europe digital PCR market, by application
      • 8.3.2.24.Rest of Europe digital PCR market, by end user
    • 8.3.3.Europe digital PCR market, by technology
    • 8.3.4.Europe digital PCR market, by product type
    • 8.3.5.Europe digital PCR market, by application
    • 8.3.6.Europe digital PCR market, by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Asia-Pacific digital PCR market, by country
      • 8.4.2.1.Japan digital PCR market, by technology
      • 8.4.2.2.Japan digital PCR market, by product type
      • 8.4.2.3.Japan digital PCR market, by application
      • 8.4.2.4.Japan digital PCR market, by end user
      • 8.4.2.5.China digital PCR market, by technology
      • 8.4.2.6.China digital PCR market, by product type
      • 8.4.2.7.China digital PCR market, by application
      • 8.4.2.8.China digital PCR market, by end user
      • 8.4.2.9.Australia digital PCR market, by technology
      • 8.4.2.10.Australia digital PCR market, by product type
      • 8.4.2.11.Australia digital PCR market, by application
      • 8.4.2.12.Australia digital PCR market, by end user
      • 8.4.2.13.India digital PCR market, by technology
      • 8.4.2.14.India digital PCR market, by product type
      • 8.4.2.15.India digital PCR market, by application
      • 8.4.2.16.India digital PCR market, by end user
      • 8.4.2.17.South Korea digital PCR market, by technology
      • 8.4.2.18.South Korea digital PCR market, by product type
      • 8.4.2.19.South Korea digital PCR market, by application
      • 8.4.2.20.South Korea digital PCR market, by end user
      • 8.4.2.21.Taiwan digital PCR market, by technology
      • 8.4.2.22.Taiwan digital PCR market, by product type
      • 8.4.2.23.Taiwan digital PCR market, by application
      • 8.4.2.24.Taiwan digital PCR market, by end user
      • 8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
      • 8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
      • 8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
      • 8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user
    • 8.4.3.Asia-Pacific digital PCR market, by technology
    • 8.4.4.Asia-Pacific digital PCR market, by product type
    • 8.4.5.Asia-Pacific digital PCR market, by application
    • 8.4.6.Asia-Pacific digital PCR market, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.LAMEA digital PCR market, by country
      • 8.5.2.1.Brazil digital PCR market, by technology
      • 8.5.2.2.Brazil digital PCR market, by product type
      • 8.5.2.3.Brazil digital PCR market, by application
      • 8.5.2.4.Brazil digital PCR market, by end user
      • 8.5.2.5.Saudi Arabia digital PCR market, by technology
      • 8.5.2.6.Saudi Arabia digital PCR market, by product type
      • 8.5.2.7.Saudi Arabia digital PCR market, by application
      • 8.5.2.8.Saudi Arabia digital PCR market, by end user
      • 8.5.2.9.South Africa digital PCR market, by technology
      • 8.5.2.10.South Africa digital PCR market, by product type
      • 8.5.2.11.South Africa digital PCR market, by application
      • 8.5.2.12.South Africa digital PCR market, by end user
      • 8.5.2.13.Rest of LAMEA digital PCR market, by technology
      • 8.5.2.14.Rest of LAMEA digital PCR market, by product type
      • 8.5.2.15.Rest of LAMEA digital PCR market, by application
      • 8.5.2.16.Rest of LAMEA digital PCR market, by end user
    • 8.5.3.LAMEA digital PCR market, by technology
    • 8.5.4.LAMEA digital PCR market, by product type
    • 8.5.5.LAMEA digital PCR market, by application
    • 8.5.6.LAMEA digital PCR market, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.BIO-RAD LABORATORIES, INC.
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
    • 9.1.6.Key strategic moves and developments
  • 9.2.4BASEBIO AG
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business Performance
  • 9.3.COMBINATI, INC.
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
    • 9.3.5.Key strategic moves and developments
  • 9.4.FLUIDIGM CORPORATION
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
  • 9.5.JN MEDSYS
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Product portfolio
    • 9.5.4.Key strategic moves and developments
  • 9.6.MERCK KGAA
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.QIAGEN N.V.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segment
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
    • 9.7.6.Key strategic moves and developments
  • 9.8.SYSMEX CORPORATION
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Business performance
  • 9.9.STILLA TECHNOLOGIES
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Product portfolio
    • 9.9.4.Key strategic moves and developments
  • 9.10.THERMO FISHER SCIENTIFIC, INC.
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.